ArticleOncotarget2017

Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways.

Mitsuho Imai-Sumida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.